Leukapheresis Market Size, Share, Growth and Forecast to 2027
The Leukapheresis Market is projected to reach USD 98 million by 2027 from USD 65 million in 2022, at a CAGR of 8.5% between 2022 and 2027. While the high cost of therapeutic leukapheresis and leukopaks is expected to restrain the global Leukapheresis market during the forecast period, the increasing incidence and prevalence of leukemia, and the high demand for leukopaks in clinical research are some of the factors set to drive the market. Leukapheresis Market Key Players: Asahi Kasei Corporation (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Terumo BCT, Inc. (US), Macopharma SA (France), and Miltenyi Biotec (Germany). Some prominent players in the leukopaks market are Discovery Life Sciences (US), StemExp...